Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
Romanian Journal of Internal Medicine
Volume 56 (2018): Issue 2 (June 2018)
Open Access
Impact of dermatologic adverse reactions on QOL in oncologic patients: results from a single-center prospective study
Maria Alexandra Barbu
Maria Alexandra Barbu
,
Cornelia Niţipir
Cornelia Niţipir
,
Theodor Voiosu
Theodor Voiosu
and
Călin Giurcăneanu
Călin Giurcăneanu
| May 17, 2018
Romanian Journal of Internal Medicine
Volume 56 (2018): Issue 2 (June 2018)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
May 17, 2018
Page range:
96 - 101
Received:
Jan 01, 2018
DOI:
https://doi.org/10.2478/rjim-2018-0002
Keywords
exanthema
,
toxicity
,
EGFR tyrosine kinase inhibitor
,
quality of life
,
chemotherapy
© 2018 Maria Alexandra Barbu et al., published by De Gruyter Open
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Maria Alexandra Barbu
“UMF Carol Davila” School of Medicine,
Bucharest
Medical Oncology Department, Elias University Emergency Hospital
Bucharest
Cornelia Niţipir
“UMF Carol Davila” School of Medicine,
Bucharest
Medical Oncology Department, Elias University Emergency Hospital
Bucharest
Theodor Voiosu
“UMF Carol Davila” School of Medicine,
Bucharest
Călin Giurcăneanu
“UMF Carol Davila” School of Medicine,
Bucharest
Dermatooncology Department, Elias University Emergency Hospital
Bucharest